These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11016940)
41. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. El Mabrouk M; Touyz RM; Schiffrin EL Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H30-9. PubMed ID: 11406465 [TBL] [Abstract][Full Text] [Related]
42. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. Ushio-Fukai M; Alexander RW; Akers M; Griendling KK J Biol Chem; 1998 Jun; 273(24):15022-9. PubMed ID: 9614110 [TBL] [Abstract][Full Text] [Related]
43. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. De Windt LJ; Lim HW; Taigen T; Wencker D; Condorelli G; Dorn GW; Kitsis RN; Molkentin JD Circ Res; 2000 Feb; 86(3):255-63. PubMed ID: 10679475 [TBL] [Abstract][Full Text] [Related]
44. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy. Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373 [TBL] [Abstract][Full Text] [Related]
45. Stretch-induced MAP kinase activation in cardiomyocytes of angiotensinogen-deficient mice. Nyui N; Tamura K; Mizuno K; Ishigami T; Hibi K; Yabana M; Kihara M; Fukamizu A; Ochiai H; Umemura S; Murakami K; Ohno S; Ishii M Biochem Biophys Res Commun; 1997 Jun; 235(1):36-41. PubMed ID: 9196031 [TBL] [Abstract][Full Text] [Related]
46. Role of calcineurin in insulin-like growth factor-1-induced hypertrophy of cultured adult rat ventricular myocytes. Miyashita T; Takeishi Y; Takahashi H; Kato S; Kubota I; Tomoike H Jpn Circ J; 2001 Sep; 65(9):815-9. PubMed ID: 11548882 [TBL] [Abstract][Full Text] [Related]
47. The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes. Wei C; Cardarelli MG; Downing SW; McLaughlin JS J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):379-84. PubMed ID: 11967827 [TBL] [Abstract][Full Text] [Related]
48. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Molkentin JD Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472 [TBL] [Abstract][Full Text] [Related]
49. [Role of valsartan on myocardial Calpain I, calcineurin and Ca/calmodulin-dependent protein kinase IIδ expression of renovascular hypertensive rats]. Lu JY; Zhu JH; Qin XT; Yu XH; Sheng HZ Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):511-5. PubMed ID: 22943648 [TBL] [Abstract][Full Text] [Related]
50. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
51. Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice. Martínez-Martínez S; Lozano-Vidal N; López-Maderuelo MD; Jiménez-Borreguero LJ; Armesilla ÁL; Redondo JM FEBS J; 2019 Jan; 286(1):46-65. PubMed ID: 30548183 [TBL] [Abstract][Full Text] [Related]
52. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206 [TBL] [Abstract][Full Text] [Related]
54. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657 [TBL] [Abstract][Full Text] [Related]
55. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Taigen T; De Windt LJ; Lim HW; Molkentin JD Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1196-201. PubMed ID: 10655507 [TBL] [Abstract][Full Text] [Related]
56. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Esposito G; Prasad SV; Rapacciuolo A; Mao L; Koch WJ; Rockman HA Circulation; 2001 Mar; 103(10):1453-8. PubMed ID: 11245652 [TBL] [Abstract][Full Text] [Related]
57. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146 [TBL] [Abstract][Full Text] [Related]
58. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes. Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329 [TBL] [Abstract][Full Text] [Related]